118 related articles for article (PubMed ID: 36581779)
1. ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
Sloan AE; Nock CJ; Ye X; Buerki R; Chang S; Lesser G; Norden A; Cloughesy T; Olson J; Kerstetter-Fogle A; Rich J; Fisher J; Desideri S; Takebe N; Timmer W; Grossman S; Prados M
J Neurooncol; 2023 Jan; 161(1):33-43. PubMed ID: 36581779
[TBL] [Abstract][Full Text] [Related]
2. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway.
Yan GN; Yang L; Lv YF; Shi Y; Shen LL; Yao XH; Guo QN; Zhang P; Cui YH; Zhang X; Bian XW; Guo DY
J Pathol; 2014 Sep; 234(1):11-22. PubMed ID: 24604164
[TBL] [Abstract][Full Text] [Related]
4. Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.
Tu Y; Niu M; Xie P; Yue C; Liu N; Qi Z; Gao S; Liu H; Shi Q; Yu R; Liu X
Sci Rep; 2017 Feb; 7():42630. PubMed ID: 28195165
[TBL] [Abstract][Full Text] [Related]
5. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.
Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H
J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601
[TBL] [Abstract][Full Text] [Related]
6. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
[TBL] [Abstract][Full Text] [Related]
7. Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes.
Bassoy EY; Chiusolo V; Jacquemin G; Riccadonna C; Walker PR; Martinvalet D
PLoS One; 2016; 11(4):e0153433. PubMed ID: 27073883
[TBL] [Abstract][Full Text] [Related]
8. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
9. ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.
Liu Y; Luan Y; Ma K; Zhang Z; Liu Y; Chen X
Stem Cells Dev; 2022 May; 31(9-10):258-268. PubMed ID: 35403434
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
11. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
[TBL] [Abstract][Full Text] [Related]
12. A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
Peereboom DM; Ye X; Mikkelsen T; Lesser GJ; Lieberman FS; Robins HI; Ahluwalia MS; Sloan AE; Grossman SA
Neurosurgery; 2021 Jan; 88(2):246-251. PubMed ID: 33027815
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance.
Kostopoulou ON; Mohammad AA; Bartek J; Winter J; Jung M; Stragliotto G; Söderberg-Nauclér C; Landázuri N
Int J Cancer; 2018 Mar; 142(6):1266-1276. PubMed ID: 29067692
[TBL] [Abstract][Full Text] [Related]
14. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
16. Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.
Lee D; Gimple RC; Wu X; Prager BC; Qiu Z; Wu Q; Daggubati V; Mariappan A; Gopalakrishnan J; Sarkisian MR; Raleigh DR; Rich JN
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36394953
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
18. Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trial.
Oehler C; Frei K; Rushing EJ; McSheehy PM; Weber D; Allegrini PR; Weniger D; Lütolf UM; Knuth A; Yonekawa Y; Barath K; Broggini-Tenzer A; Pruschy M; Hofer S
Oncology; 2012; 83(1):1-9. PubMed ID: 22688083
[TBL] [Abstract][Full Text] [Related]
19. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract][Full Text] [Related]
20. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
